JHS Svendgaard Laboratories Ltd. — Interim / Quarterly Report 2022

Aug 10, 2021

August 10, 2021

BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai — 400 001 Mumbai — 400 051

Scrip Code: 532771 Trading Symbol: JHS

Sub: Outcome of Meeting of Board of Directors held on Tuesday, 10" August,2021

Dear Sir/ Madam,

In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform.your good office that the Board of Directors of JHS Svendgaard Laboratories Limited ("the Company") at their meeting held today i.e. on Tuesday, 10'" August, 2021 has, inter alia, considered and approved:

• 1. Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30" June, 2021.
• 1. Appointment of Mr. Neeraj Kumar as Joint Chief Financial Officer of the Company w.e.f 10" August,2021,

The meeting of the Board of Directors commenced at | 2-+2O© P.M. and concluded at 2:20 pM.

A Copy such Results along with Limited Review Reports thereon are enclosed as Annexure — A. Further, the brief details of the Joint Chief Financial Officer as mentioned in item no. 2 is enclosed in Annexure - B.

These results are also being made available on the website of the Company at https://Awww.svendgaard.com.

You are requested to kindly take the above information in your records.

Encl: A/a

Tel. : +91-1702-302119/121/102 - Fax : +91-1702-302125 A | ME ] 7 ry Registered Office : Trilokpur Road, Kheri (Kala-Amb), Tehsil-Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA

S. N. Dhawan & co LLP Gurugram, Haryana 122046, india

Chartered Accountants Tel +91 124 484 4444

pea NE MuRt PR

4214, li Floor, Udyog Vihar Phase IV,

Limited Review Report on Unaudited Standalone Financial Results for the Quarter Ended 30 June 2021

To the Board of Directors of JHS Svendgaard Laboratories Limited

• . We have reviewed the accompanying statement of unaudited standalone financial results of JHS Svendgaard Laboratories Limited ('the Company") for the quarter ended 30 June 2021 ("the Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India ("the SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This Statement which is the responsibility of the Company's Management and approved by the Board of Directors, has been prepated in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' (Ind AS 34%, prescribed under Section 133 of the Companies Act, 2013 ('the Act") read with relevant Rules issued thereunder; as applicable and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review.
• . We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India. This standard requites that we plan and perform the review to obtain moderate assutance as to whether the Statement is free of material misstatement. A teview is limited primarily to inquirics of Company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
• . Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement ptinciples laid down in the aforesaid Ind AS and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.

For S.N. Dhawan & Co LLP Chartered Accountants Firm Registration No.: 000050N/N500045

gitally signed by SURINDER UGA KHATTAR D 08,10 19:55:47 KHATTAR'

Surinder Kr. Khattar Partner Membership No.: 084993 UDIN 21084993AAAADE1616

Place: New Delhi Date: 10 August 2021

JHS SVENDGAARD LABORATORIES LIMITED

STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE , 2021

	JHS SVENDGAARD LABORATORIES LIMITED
	Regd. Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA
	CIN-L24230HP2004PLC027558STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE , 2021
S.No.	Particulars	Quarter Ended30th June 2021Unaudited	Quarter Ended31st March 2021Audited	Quarter Ended30th June 2020 31st March 2021Unaudited	(7 in lakhsYear EndedAudited
1	Income(a) Revenue from operations	2,024.62	2,496.21	1,611.45	9,696.15
	(b) Other income	227.132,251.75	324.152,820.36	167.301,778.75	554,7810,250.93
2	Total income_ Expenses
	(a) Cost of materials consumed	1,353.8657.99	1,436.72-	1,335.6126.78	6,402.24100.63
	(b) Purchases of stock-in-trade(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	113.39	79.77	160.07	179.83
	(d) Employee benefits expense	223.15	294.8112:57	124.3011.91	838.0345.25
	(¢) Finance costs	10.48144.73	136.38	138.88	556,43
	(f) Depreciation and amortisation expenses(g) Other expenses	299,32	624,24	195.17	1,808.81
	Total expenses	2,202.92	2,584.49	1,992.72	9,931.22319.71
3	Profit/(loss) before exceptional items and tax (1-2)	48.83	235.87-	(213.97)e	-
4	Exceptional items Profit/(loss) before tax (3+4)	:48.83	235,87	(213.97)	319.71
56	Tax expense/(income)
	Current Tax	2.26	28,12	-(15.69)	52:57121.95
	Deferred Tax (including MAT Credit Entitlement)	13.09-	64.32(131.42)	-	(131.42)
7	Tax for earlier years Net Profit/(loss) for the period (5-6)	33.48	274.85	(198.28)	276.61
8	Other comprehensive income
	(a) -Items that will not be reclassified to profit or loss	1.63	8.13	(0.53)	6.53
	-Income tax relating to items that will not be reclassified to profit or loss	(0.45)-	(2.26)-	0.15-	(1.82)-
	(b) -Items that will be reclassified to profit or loss-Income tax relating to items that will be reclassified to profit or loss	-	-	-	-
9	Total comprehensive income for the period (7+8)	34.66	280.72	(198.66)	281.32
1011	Paid-up equity share capital (Face value per share Rs. 10/-)of previousbalancesheetrevaluationreservesperexcluding[Reserveasaccounting year	6,440.05-	6,440.05=	6,090.05-	6,440.0512,707.76
12.	Earnings per equity share
	(a) Basic (Rs.)(b) Diluted (Rs.)	0.050.05	0.440.44	(0.33)(0.33)	0.450.45

Notes:

• 1 The above unaudited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in the respective meetings held on 10th August, 2021 . The same have been reviewed by the Statutory Auditors of the Company as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulation, 2015.
• 2 In line with the provisions of Ind AS 108 Operating Segments and on the basis the review of operations being done by the Management, the operations of the Company fall under Manufacturing of Oral Care products, which is considered to be the only reportable segment by the management,
• 3 The Company has considered the possible effects that may result from the pandemic on the carrying amounts of its property, plant and equipment, investments, inventories, receivables and other current assets and liabilities. The Company has also evaluated its liquidity position, recoverability of its assets and based on current estimates expects that the carrying amount of these assets will be recovered. Further, the Company has considered internal and external information upto the date of approval of these standalone financial results. Based on the above, there has been no material impact on the operations or profitability of the Company due to this pandemic.
• 4 Deferred tax includes MAT credit entitlement of Rs. 2.26 Lakhs for the current quarter 30th June , 2021,
• 5 Figures of the quarter ended 31st March, 2021 are balancing figures between audited figures for the full financial year and the reviewed year to date figures upto the third quarter of the said financial year.
• 6 Figures for the previous quarters/years have been regrouped and reclassified to conform with current quarter/year presentation, where ever applicable.

§ Labo For and on behag Managing Dire

Place : New Delhi Date : 10th August, 2021

S.N. Dhawan & co LLP Gurugram, Haryana 122018, India

Chartered Accountants Tel +91 124 481 4444

424, Il Floor, Udyog Vihar Phase lV,

Limited Review Report on Consolidated Unaudited Financial Results for the Quarter Ended 30 June 2021

To the Board of Directors of JHS Svendgaard Laboratories Limited

• . We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of JHS Svendgaard Laboratories Limited ("the Patent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group"), for the quarter ended 30 June 2021 ("the Statement"), being submitted by the Parent pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India ("the SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
• . This Statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, tread with relevant tules issued thereunder, as applicable and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.
• | We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We also performed procedutes in accordance with the circular issued by the SEBI under Regulation 33 (8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable.

	St.no. Name of Entities	Relationship
1	LimitedSvendgaardBrandsJHSknown as JHS Svendgaard Dental Cate Limited), control)	(byvirtueof(formerly Subsidiary
2	SvendgaardMechanicalWarehouse SubsidiaryJHSandPrivate Limited
3	JHS Svendgaard Retail Ventures Private Limited Subsidiary

. The Statement includes the results of the following entities:

. Based on our review conducted and procedutes performed as stated in paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Ind AS and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.

1. We did not review the interim financial results of three subsidiaries included in the statement, whose nancial results reflect total revenues of Rs 133.92 lakhs, total net loss after tax of Rs, 62.05 lakhs and total comprehensive loss of Rs 61.02 lakhs (after eliminating intra-group transactions) lakhs for the quarter ended 30 June 2021, as considered in the statement. The interim financial results of these subsidiaries have been reviewed by the other auditors whose teports have been furnished to us by the management, and our conclusion in so fat as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the report of other auditors and the procedures performed by us as stated in paragraph 3 above.

Our conclusion on the Statement is not modified in respect of the above matter.

For S.N. Dhawan & Co LLP Chartered Accountants Firm Registration No.: 000050N/N500045

5 Digitally signed SURIN DER by SURINDER KUMAR _ ¢ 'KUMAR KHATTAR gy Data?202 1.08.10 KH ATTAR 13:56:36 +05'30'

Surinder Kr. Khattar Partner Membership No.: 084993 UDIN 21084993AAAADF3256

Place: New Delhi Date: 10 August 2021

JHS SVENDGAARD LABORATORIES LIMITED

STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE , 2021

	JHS SVENDGAARD LABORATORIES LIMITEDRegd. Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA
	CIN-L24230HP2004PLC027558
	STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE , 2021
		Quarter	Quarter Ended	Quarter	(@ in lakhs)Year
S.No.	Particulars	Ended 30thJune 2021	31st March2021	Ended 30th Ended 31stJune 2020 March 2021
		Unaudited	Audited	Unaudited	Audited
1	[Income(a) Revenue from operations	2,158.54	2,538.05	1,677.34	10,076.52
	(b) Other income	257.76	438,83	195,79	754.40
2	Total income Expenses	2,416.30	2,976.88	1,873.13	10,830.92
	(a) Cost of materials consumed	1,387.88	1,436.71	1,335.61	6,402.24
	(b) Purchase of stock-in-trade:soevcsoFfini=ane(c) Changes in inventories of finished goods, work-in-progress and	68.05157.10	68.76(9.32)	32.36197.43	283.99147.67
	stock-in-trade
	(d) Employee benefits expense(e) Finance Costs	259.0324.37	337.2131.02	162.1432.51	1,008.17123.99
	(f) Depreciation and amortisation expense	179.45	161.50
				190.57	725,47
	(g) Other expenses	356.33	699.27	241.40	2,042.6110,734.14
3	Total expensesProfit rofit / / (Loss) (Loss) bef before exceptional ceptional Items Items and I te tax (1-2) 1-2	2,432.21(15.91)	2,725.15351.73	2,192.02(318.89)	96.78
		i	a	=	-
45	Exceptional items Profit/ (Loss) before tax (3+4)	(15.91)	251.73	(318.89)	96.78
6	Tax expense/(income)	2.26	28.12	-	52.57
	Current TaxDeferred Tax ( including MAT Credit Entitlement )	10.40	69.78	(68.66)	41.39
	Tax for earlier years	-	(131,42)285,25	-(250,23)	(131.42)134.24
7g	Net Profit / (Loss) for the period (5-6) Other comprehensive income	(28.57)
	(a) _ -Items that will not be reclassified to profit or loss-Income tax relating to items that will not be reclassified to profit or loss	3.02(0.81)	10.34(2.84)	1.12(0.28)	12.06(3.26)
	(b) -Items that will be reclassified to profit or loss	-:	=:	&-	==
9	-Income tax relating to items that will be reclassified to profit or loss Total comprehensive income (7+8)	(26.36)	292.75	(249.39)	143.04
	Net profit attributable to:Owners of the Company	(22.54)	263.12	(251.88)	119,82
	Non-controlling interestOther Comprehensive Income attributable to:	(6.03)#	22.13	1.65	14,42
	Owners of the Company	1.610.60	6.600.90	0.240.60	6.592.21
	Non-controlling interestTotal Comprehensive Income attributable to:	=			126.41
	Owners of the CompanyNon-controlling interest	(20.92)(5.44)	269.7223.03	(251.64)2.25	16.63
10	Paid-up equity share capital ( Face value per share Rs. 10/-)	6,440.05	6,440.05	6,090.05	6,440.05
i	Reserve. excluding revaluation reserves as per balance sheet of previousaccounting year				12,429.50
	12__ Earnings per equity share(a) Basic (Rs.)(b) Diluted _(Rs.)	(0.02)(0.02)	0.440.44	(0.41)(0.41)	0,200.20

JHS SVENDGAARD LABORATORIES LIMITED

Regd. Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA

Notes:

• The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in the respective meetings held on 10th August, 2021. The same have been reviewed by the Statutory Auditors of the Company as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulation, 2015.
• The consolidated financials results of the Company include financials of three subsidiaries namely JHS Svendgaard Brands Limited (formerly known as JHS Svendgaard Dental Care Limited), JHS Svendgaard Mechanical and Warehouse Private Limited & JHS Svendgaard Retail Ventures Private Limited. The details of ownership is given

JHS SVENDGAARD LABORATORIES LIMITED
	CIN-L.24230HP2004PLC027558
Exchange Board of India (Listing Obligations and Disclosure requirements) Regulation, 2015.
as below :-
Particulars	As on 30th	As on 31st
	June, 2021_	March, 2021
JHS Svendgaard Brands Limited *	42.68%99.99%	42.68%99.99%
JHS Mechanical and Warehouse Private Limited	99.82%	99.82%
JHS Svendgaard Retail Ventures Private Limited
been made to enable users of financials instruments for better undertanding, of business of group.

JHS Svendgaard Retail Ventures Private Limited * JHS Svendgaard Brands Limited has been consolidated as per the requirement of Ind As 110 "Consolidated financial statements" as it meets the creteria of "Control" definition as given in the standard ,There are no changes except shareholding in the results as it was considered as subsidiary in earlier years.

In line with the provisions of Ind AS 108 - Operating Segments and on the basis the review of operations being done by the Management, The Following disclosures have been made to enable users of financials instruments for better undertanding, of business of group.

	JHS SVENDGAARD LABORATORIES LIMITED
Regd. Office: Trilokpur Road, Kheri (Kala-Amb), Tehsil Nahan, Distt. Sirmour, Himachal Pradesh - 173030, INDIA	CIN-L.24230HP2004PLC027558
The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company in the respectivemeetings held on 10th August, 2021. The same have been reviewed by the Statutory Auditors of the Company as required under Regulation 33 of the Securities andExchange Board of India (Listing Obligations and Disclosure requirements) Regulation, 2015.The consolidated financials results of the Company include financials of three subsidiaries namely JHS Svendgaard Brands Limited (formerly known as JHS SvendgaardDental Care Limited), JHS Svendgaard Mechanical and Warehouse Private Limited & JHS Svendgaard Retail Ventures Private Limited. The details of ownership is givenas below :-	As on 30th	As on 31st
Particulars	June, 2021_	March, 2021
JHS Svendgaard Brands Limited *	42.68%	42.68%
JHS Mechanical and Warehouse Private LimitedJHS Svendgaard Retail Ventures Private Limited	99.99%99.82%	99.99%99.82%
definition as given in the standard ,There are no changes except shareholding in the results as it was considered as subsidiary in earlier years.
In line with the provisions of Ind AS 108 - Operating Segments and on the basis the review of operations being done by the Management, The Following disclosures havebeen made to enable users of financials instruments for better undertanding, of business of group.
Particulars	QuarterEnded 30thJune 2021	Quarter Ended31st March2021	QuarterEnded 30th Ended 3istJune 2020 March 2021	Year
Segment Revenue
Manufacturing business	2,024.62	2,496.21	1,611.45	9,696.15
Other than manufacturing	100.14	132.01	46.59	436.29
Retail business	45.49	54.67	25.91	186.99
Less: Inter segment revenue	(11.71)	(144.84)	(6.61)	(242.91)
Segment Results				:
Manufacturing business	33.48	274.85	(198.28)	276.61
Other than manufacturing	(10.49)	40.75	3.50	26.60
	(41.81)	(20.69)	(49.90)	(154.38)
Retail business	(9.75)	(9.66)	(5.55)	(14.59)
Less: Inter segment results
Segment Assets	21,643.39	21,448.30	21,744.99	21,448.30
Manufacturing business	3,198.43	3,233.84	2,715.36	3,233.84
Other than manufacturing	874.43	963.23	1,089.66	963.23
Retail business	(2,392.64)	(2,849,60)	_(2,636.21)	(2,849.60)
Less: Inter segment assets
Segment Liabilities	2,462.85	2,300.49	3,801.46	2,300.49
Manufacturing business	1,613.53	1,640.79	1,598.24	1,640.79
Other than manufacturingRetail business	411.56	503.54	533.29	503.54

The Company has considered the possible effects that may result from the pandemic on the carrying amounts of its property, plant and equipment, investments, inventories, receivables and other current assets and liabilities. The Company has also evaluated its liquidity position, recoverability of its assets and based on current estimates expects that the carrying amount of these assets will be recovered. Further, the Company has considered internal and external information upto the date of approval of these consolidated financial results. Based on the above, there has been no material impact on the operations or profitability of the group due to this pandemic.

• Deferred tax includes MAT credit entitlement of Rs. 2.26 Lakhs for the current quarter 30th June , 2021.
• Figures of the quarter ended 31st March, 2021 are balancing figures between audited figures for the full financial year and the reviewed year to date figures upto the third quarter of the said financial year.
• Figures for the previous quarters/years have been regrouped and reclassified to conform with current quarter/year presentation, where ever applicable.

Place : New Delhi Date : 10th August, 2021

Particulars	Quarter EndedJune 30, 2021	March 31, 2021Quarter Ended	Quarter EndedJune 30, 2020	Year ended March31, 2021
	Audited	Unaudited	Audited	Audited
1. Segment Revenue
(net sale/income from each segment should
be disclosed under this head)
(a) Manufacturing Business	2,024.62	2,496.21	1,611.45	9,696.15
Other than Manufacturing BusinessЭ	100.14	132.01	46.59	436.29
(c) Retail Businesss	45.49	54.67	25.91	186.29
Total	2,170.25	2,682.89	1,683.95	10,318.73
Less : Inter Segment Revenue	(11.70)	(144.84)	(6.61)	(242.91)
Net Sales/Income From Operations	2,158.55	2,538.05	1,677.34	10,075.82
(-) before$\frac{1}{2}$tax and interest from each segmer2. Segment Results Profit(+)/Loss
(a) Manufacturing Business	59.31	248.44	(202.06)	364.96
iness(b) Other than Manufacturing Busi	(8.54)	53.69	(28.41)	8.65
(c) Retail Businesss	(28.82)	(14.61)	(48.42)	(141.42)
Total	21.95	287.52	(278.89)	232.19
3. Segment Assets
(a) Manufacturing Business	21,643.39	21,448.30	21,744.99	21,448.30
(b) Other than Manufacturing Business	3,198.43	3,233.84	2,715.36	3,233.84
(c) Retail Businesss	874.43	963.23	1,089.66	963.23
Less: Inter Segment Assets	(2, 392.64)	(2, 849.60)	(2,636.21)	(2,849.60)
Total	23,323.61	22,795.77	22,913.80	22,795.77
4. Segment Liabilities
(a) Manufacturing Business	2,462.85	2,300.49	3,801.46	2,300.49
(b) Other than Manufacturing Business	1,613.53	1,640.79	1,598.24	1,640.79
(c) Retail Businesss	411.56	503.54	533.29	503.54
Less: Inter Segment Liabilities	(992.98)	(1,445.13)	(1,340.72)	(1,445.13)
Total	3,494.96	2,999.69	4,592.27	2,999.69

ANNEXURE- B

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

	ANNEXURE- B
	Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015
Particulars	Mr. Neeraj Kumar
Appointment/viz.ChangeReasonfor	Appointment as Joint Chief Financial Officer (Key
resignation/ removal/ death or otherwise	Managerial Personnel)
Brief Profile	sinceGrouppartofJHSKumarisNeeraj
	CharteredQualifiedisa2011andDecember
	inExperienceyears+with10AccountantAccounting,CorporateFinance&Tax
	HTexperiencewithworkhavingManagement,
	Media Lid. , India Today Group , Dr. Fresh Inc.
	(USA) responsible for the Vendor Management ,
	AccountingCost&Control,Statutory
	Compliances, CommercialDecisions.